Role of heme in phenobarbital induction of cytochromes P450 and 5-aminolevulinate synthase in cultured rat hepatocytes maintained on an extracellular matrix

https://doi.org/10.1016/0003-9861(90)90133-JGet rights and content

Abstract

When hepatocytes are cultured on matrigel, a reconstituted basement membrane matrix, mRNAs for cytochrome P450 class IIB1/2 and class III genes can be induced by treatment with phenobarbital. We took advantage of this new system to critically evaluate the role of heme as a regulator of these cytochromes P450 and of 5-aminolevulinate synthase (ALA-S), the rate-limiting enzyme in heme biosynthesis. Phenobarbital treatment of rat cultures increased the total amount of cytochrome P450, activities catalyzed by IIB1/2 (benzyloxy- and pentoxyresorufin O-dealkylases) and ALA-S activity, and ALA-S mRNA. Treatments with phenobarbital combined with succinyl acetone, an inhibitor of heme biosynthesis at the step of 5-aminolevulinate dehydrase, blocked the induction of the proteins for cytochrome P450IIB1/2 and cytochrome P450IIIAI, as indicated by spectral, immunological, and enzymatic assays. However, at the same time, succinyl acetone cotreatment failed to inhibit the induction of the mRNAs for cytochrome P450IIB1/2 and cytochrome P450IIIA. Lack of effect on the cytochrome P450 mRNAs was selective inasmuch as treatment with phenobarbital combined with succinyl acetone synergistically increased both ALA-S activity and ALA-S mRNA, presumably by blocking formation of heme, the feedback repressor of ALA-S. Indeed, the increase in ALA-S mRNA caused by the combined treatment was abolished by adding heme itself to the cultures. In contrast to earlier concepts, we conclude that in the intact hepatocyte, phenobarbital-induced cytochrome P450 induction is independent of changes in heme synthesis.

References (44)

  • V.J. Dwarki et al.

    J. Biol. Chem

    (1987)
  • R.P. Evarts et al.

    Biochem. Pharmacol

    (1984)
  • E.G. Schuetz et al.

    J. Biol. Chem

    (1984)
  • J. Sinclair et al.

    Biochem. Pharmacol

    (1981)
  • R.A. Lubet et al.

    Mutat. Res

    (1985)
  • M.D. Burke et al.

    Biochem. Pharmacol

    (1985)
  • T. Omura et al.

    J. Biol. Chem

    (1964)
  • P. Sinclair et al.

    Anal. Biochem

    (1977)
  • D.J. Waxman et al.

    J. Biol. Chem

    (1988)
  • O.H. Lowry et al.

    J. Biol. Chem

    (1951)
  • M. Adesnik et al.

    J. Biol. Chem

    (1981)
  • G. Srivastava et al.

    J. Biol. Chem

    (1988)
  • B. Grandchamp et al.

    J. Biol. Chem

    (1981)
  • P.R. Sinclair et al.

    Biochem. Pharmacol

    (1982)
  • B.K. May et al.

    Curr. Topics Cell. Regul

    (1986)
  • P.D. Drew et al.

    Biochem. Biophys. Res. Comman

    (1989)
  • E-M. Suolinna et al.

    Biochem. Pharmacol

    (1986)
  • P.B. Watkins et al.

    J. Biol. Chem

    (1986)
  • A. Kumar et al.

    J. Biol. Chem

    (1983)
  • R.A. Galbraith

    Ann. N.Y. Acad. Sci

    (1987)
  • H. Ravishankar et al.

    J. Biol. Chem

    (1986)
  • G. Srivastava et al.

    Eur. J. Biochem

    (1989)
  • Cited by (0)

    This research was supported by National Institute of Health Grants CA 25012, AA07146, ESO 3699, DK 30203, DK 37261, and GM 32281 and ESO 4628 and by funds from the Department of Veterans Affairs.

    View full text